Author

Désiré Takou

Observed names: D Takou, D. Takou, Desire Takou, Desiré Takou, Désire Takou, Désiré A Takou Komego, Désiré Augustin Komego Takou, Désiré Augustin Takou Komego, Désiré K. Takou, Désiré Komego Takou, Takou Desire, Takou Désire, Takou, Desire, Takou, Desiré

Institutions: Centre International De Reference Chantal Biya, Ministry of Public Health

Observed institutions: University of Rome Tor Vergata, Centre International De Reference Chantal Biya, Ministry of Public Health

ORCID: 0000-0003-2601-7508

Observed ORCID: 0000-0003-2601-7508

OpenAlex ID: A5108775788

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

2022 · Houriiyah Tegally, James E. San, et al. · Science · 192

Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of “test and treat”

2019 · Joseph Fokam, Samuel Martin Sosso, et al. · AIDS Research and Therapy · 63

SARS-CoV-2 Antibody Seroprevalence and Associated Risk Factors in an Urban District in Cameroon

2021 · Kene Nwosu, Joseph Fokam, et al. · Nature Communications · 59

Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon

2011 · J. Fokam, R. Salpini, et al. · Archives of Virology · 54

Drug Resistance Among Drug-naive and First-line Antiretroviral Treatment-failing Children in Cameroon

2011 · Joseph Fokam, Romina Salpini, et al. · The Pediatric Infectious Disease Journal · 49

Diagnostic performance of a colorimetric RT -LAMP for the identification of SARS-CoV-2: A multicenter prospective clinical evaluation in sub-Saharan Africa

2021 · Marycelin Mandu Baba, Molalegne Bitew, et al. · EClinicalMedicine · 45

HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon

2019 · Desire Takou, Joseph Fokam, et al. · BMC Infectious Diseases · 37

Characterization of drug resistance mutations in naïve and ART‐treated patients infected with HIV‐1 in Yaounde, Cameroon

2012 · Laura Ceccarelli, Romina Salpini, et al. · Journal of Medical Virology · 36

Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals

2022 · Alex Durand Nka, Yagai Bouba, et al. · Journal of Antimicrobial Chemotherapy · 32

Alarming rates of virological failure and HIV‐1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY‐study in Cameroon

2021 · J Fokam, D Takou, et al. · HIV Medicine · 32

Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics

2023 · Joseph Fokam, Alex Durand Nka, et al. · Medicine · 31

Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains

2017 · Lavinia Fabeni, Giulia Berno, et al. · Journal of Clinical Microbiology · 31

Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model

2022 · Ezechiel Ngoufack Jagni Semengue, Joseph Fokam, et al. · Viruses · 29

Current knowledge of human Mpox viral infection among healthcare workers in Cameroon calls for capacity-strengthening for pandemic preparedness

2024 · Alex Durand Nka, Yagai Bouba, et al. · Frontiers in Public Health · 27

Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy

2018 · Judith N. Torimiro, Aubin Nanfack, et al. · BMC Pregnancy and Childbirth · 26

Lipid Peroxidation and Total Cholesterol in HAART-Naïve Patients Infected with Circulating Recombinant Forms of Human Immunodeficiency Virus Type-1 in Cameroon

2013 · Georges Teto, Georgette D. Kanmogne, et al. · PLoS ONE · 26

Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé

2019 · Alex Durand Nka, Samuel Martin Sosso, et al. · BMC Research Notes · 25

Molecular Epidemiology of HIV Type 1 CRF02_AG in Cameroon and African Patients Living in Italy

2011 · Nazle Mendonca Collaço Véras, Maria Mercedes Santoro, et al. · AIDS Research and Human Retroviruses · 25

Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings

2021 · Ezechiel Ngoufack Jagni Semengue, Daniele Armenia, et al. · Journal of Antimicrobial Chemotherapy · 24

HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis

2022 · Ezechiel Ngoufack Jagni Semengue, Maria Mercedes Santoro, et al. · PLOS Global Public Health · 22

Genomic surveillance of SARS-CoV-2 reveals highest severity and mortality of delta over other variants: evidence from Cameroon

2023 · Joseph Fokam, Rene Ghislain Essomba, et al. · Scientific Reports · 21

Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens

2023 · Joseph Fokam, Collins Ambe Chenwi, et al. · Viruses · 20

First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens

2020 · Joseph Fokam, Desire Takou, et al. · Antimicrobial Resistance and Infection Control · 18

Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study)

2019 · Joseph Fokam, Maria Mercedes Santoro, et al. · BMC Pediatrics · 17

Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon

2020 · Joseph Fokam, Desire Takou, et al. · PLoS ONE · 16

Works count: 125

Citation count: 1,267

H-index: 21

I10-index: 36